(Q36618333)

15 August 2017

1 reference

title

Perioperative uses of histamine antagonists (English)

1 reference

15 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702978

Anesthesiology and pain medicine

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

3 November 2022

author name string

W. Lorenz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702978

3 November 2022

M. Ennis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702978

3 November 2022

A. Doenicke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702978

3 November 2022

W. Dick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1702978

3 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1702978

3 November 2022

publication date

1 September 1990

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:095281809090083F?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

https://api.elsevier.com/content/article/PII:095281809090083F?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Journal of Clinical Anesthesia

3 November 2022

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

345-360

1 reference

Histamine release in man by propanidid and thiopentone: pharmacological effects and clinical consequences.

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine release after intravenous application of short-acting hypnotics. A comparison of etomidate, Althesin (CT1341) and propanidid.

3 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Severe histamine mediated reactions to intravenous drugs used in anaesthesia

3 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine and antihistamines in anaesthesia and surgery. Symposium, June 3-5, 1981, Munich

3 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine Release by Narcotics and Muscle Relaxants in Humans

3 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine release in man.

3 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine and cardiac arrhythmias

3 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine liberation induced by anesthetics or their solvents: specific or non-specific?

3 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

An improved method for the determination of histamine release in man: its application in studies with propanidid and thiopentone

3 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: Studies in the conscious human subject

3 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor El (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions?

3 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Plasma histamine profiles in paediatric cardiopulmonary bypass

3 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responses

3 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Effects of infused histamine: Correlation of plasma histamine levels and symptoms

3 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Release of histamine by H2-receptor antagonists

3 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Functional heterogeneity of mast cells from different species and tissues

3 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine antagonists and d-tubocurarine-induced hypotension in cardiac surgical patients

3 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Hypotension and bradycardia elicited by histamine into the C1 area of the rostral ventrolateral medulla

3 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Plasma histamine levels in polytraumatized patients

3 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Elevated plasma histamine concentrations in surgery: causes and clinical significance

3 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Immunological and non-immunological mechanisms involved in adverse reactions to drugs

3 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine release with intravenous narcotics: Protective effects of H1 and H2-receptor antagonists

3 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response

3 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Plasma histamine levels following atracurium.

3 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine release by neuromuscular blocking agents in man

3 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine release in anaesthesia and surgery. Premedication with H1- and H2-receptor antagonists: Indications, benefits and possible problems

3 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

H1+H2-receptor antagonists for premedication in anaesthesia and surgery: A critical view based on randomized clinical trials with haemaccel and various antiallergic drugs

3 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin

3 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Histamine release and hepatic elimination of histamine following abdominal surgery

3 November 2022

70

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Plasma histamine levels in patients in the course of several standard operations: influence of anaesthesia, surgical trauma and blood transfusion.

3 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

The clinical significance of elevated CSF and plasma histamine in cerebral aneurysm surgery utilizing cardiopulmonary bypass with total circulatory arrest

3 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Plasma histamine profiles in paediatric cardiopulmonary bypass

3 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Definition and antagonism of histamine H 2 -receptors

3 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Pathophysiological significance of the distribution of histamine receptor sub-types: a proposed dual role for histamine in inflammation and type I hypersensitivity reactions

3 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

A third histamine receptor subtype: Characterisation, localisation and functions of the H3-receptor

3 November 2022

79

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Highly potent and selective ligands for histamine H3-receptors

3 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine

3 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine.

3 November 2022

82

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

The mode of action of promethazine in potentiating narcotic drugs.

3 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Actions of cimetidine and ranitidine at some cholinergic sites: implications in toxicology and anesthesia

3 November 2022

90

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

H2 antagonists and bupivacaine clearance.

3 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Effects of H-2 antagonists on the elimination of bupivacaine.

3 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Effect of cimetidine and ranitidine on lidocaine concentrations during epidural anesthesia for cesarean section

3 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients

3 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study.

3 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Prevention of histamine-induced cardiovascular reactions during the induction of anaesthesia following premedication with H1- + H2-antagonists i.m.

3 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Prophylaxis of anaphylactoid reactions to a polypeptidal plasma substitute by H1- plus H2-receptor antagonists: synopsis of three randomized controlled trials

3 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial

3 November 2022

102

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

Effects of antihistamines on isolated rat peritoneal mast cells and on model membrane systems

3 November 2022

104

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

The Effects of the Immunologic Release of Histamine upon Human Lung Cyclic Nucleotide Levels and Prostaglandin Generation

3 November 2022

105

1 reference

https://api.crossref.org/works/10.1016/0952-8180(90)90083-F

3 November 2022

Identifiers

1 reference

15 August 2017

1 reference